Invasive liver abscess syndrome due to hypervirulent Klebsiella pneumoniae poses significant mortality risk, particularly in immunocompromised patients. Early recognition in non-endemic regions is crucial for prompt antibiotic therapy and source control, highlighting the need for increased suspicion and aggressive management of this rare disease to improve patient outcomes.
Keywords: Hypervirulent klebsiella pneumoniae; invasive liver abscess syndrome; splenectomy; uncontrolled diabetes mellitus.
© 2025 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.